Viewing Study NCT03114657


Ignite Creation Date: 2025-12-24 @ 6:30 PM
Ignite Modification Date: 2026-01-04 @ 4:22 PM
Study NCT ID: NCT03114657
Status: TERMINATED
Last Update Posted: 2020-07-16
First Post: 2017-03-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
Sponsor: Hoffmann-La Roche
Organization: